These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

754 related items for PubMed ID: 17214099

  • 1. Should bone marrow examination be routinely performed for the diagnosis of monoclonal gammopathy of undetermined significance?
    Elis A, Radnay J, Shapiro H, Itzhaky D, Manor Y, Lishner M.
    Isr Med Assoc J; 2006 Dec; 8(12):840-2. PubMed ID: 17214099
    [Abstract] [Full Text] [Related]

  • 2. Differentiation of monoclonal gammopathy of undetermined significance and multiple myeloma using flow cytometric characteristics of plasma cells.
    Sezer O, Heider U, Zavrski I, Possinger K.
    Haematologica; 2001 Aug; 86(8):837-43. PubMed ID: 11522540
    [Abstract] [Full Text] [Related]

  • 3. HIV-associated monoclonal gammopathy: a retrospective analysis of 25 patients.
    Amara S, Dezube BJ, Cooley TP, Pantanowitz L, Aboulafia DM.
    Clin Infect Dis; 2006 Nov 01; 43(9):1198-205. PubMed ID: 17029142
    [Abstract] [Full Text] [Related]

  • 4. Diagnostic criteria of multiple myeloma.
    Kyle RA.
    Hematol Oncol Clin North Am; 1992 Apr 01; 6(2):347-58. PubMed ID: 1582977
    [Abstract] [Full Text] [Related]

  • 5. Biclonal gammopathy in multiple myeloma: a case report.
    Bakta IM, Sutarka IN.
    Gan To Kagaku Ryoho; 2000 May 01; 27 Suppl 2():544-8. PubMed ID: 10895208
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Kynurenic acid in blood and bone marrow plasma of monoclonal gammopathy of undetermined significance (MGUS) and multiple myeloma (MM) patients.
    Zdzisińska B, Wejksza K, Walter-Croneck A, Turski WA, Kandefer-Szerszeń M.
    Leuk Res; 2010 Jan 01; 34(1):38-45. PubMed ID: 19596432
    [Abstract] [Full Text] [Related]

  • 9. Monoclonal gammopathy of undetermined significance and smoldering multiple myeloma.
    Kyle RA, Rajkumar SV.
    Hematol Oncol Clin North Am; 2007 Dec 01; 21(6):1093-113, ix. PubMed ID: 17996590
    [Abstract] [Full Text] [Related]

  • 10. [The CBO professional guideline 'monoclonal gammopathy' (paraproteinemia) (revision)].
    Buiting AM, Wijermans PW.
    Ned Tijdschr Geneeskd; 2002 Jul 27; 146(30):1406-11. PubMed ID: 12174434
    [Abstract] [Full Text] [Related]

  • 11. Multiple myeloma arising from monoclonal gammopathy of undetermined significance in a patient with Gaucher's disease.
    Brady K, Corash L, Bhargava V.
    Arch Pathol Lab Med; 1997 Oct 27; 121(10):1108-11. PubMed ID: 9341594
    [Abstract] [Full Text] [Related]

  • 12. Monoclonal gammopathy of undetermined significance and smoldering multiple myeloma.
    Kyle RA, San-Miguel JF, Mateos MV, Rajkumar SV.
    Hematol Oncol Clin North Am; 2014 Oct 27; 28(5):775-90. PubMed ID: 25212882
    [Abstract] [Full Text] [Related]

  • 13. [Monoclonal gammopathy--multiple myeloma].
    Dietzfelbinger H.
    MMW Fortschr Med; 2005 Jun 16; 147(24):32-3, 35-6. PubMed ID: 16001531
    [Abstract] [Full Text] [Related]

  • 14. Criteria for the classification of monoclonal gammopathies, multiple myeloma and related disorders: a report of the International Myeloma Working Group.
    International Myeloma Working Group.
    Br J Haematol; 2003 Jun 16; 121(5):749-57. PubMed ID: 12780789
    [Abstract] [Full Text] [Related]

  • 15. Monoclonal gammopathies of undetermined significance.
    Kyle RA, Rajkumar SV.
    Best Pract Res Clin Haematol; 2005 Jun 16; 18(4):689-707. PubMed ID: 16026745
    [Abstract] [Full Text] [Related]

  • 16. [Study of monoclonal gammopathy in Kagawa Prefectural Central Hospital].
    Uchida M, Taida N, Kanao M, Kagamihara H, Kuwajima M.
    Rinsho Byori; 2004 Jul 16; 52(7):574-9. PubMed ID: 15344556
    [Abstract] [Full Text] [Related]

  • 17. Neural cell adhesion molecule expression in plasma cells in bone marrow biopsies and aspirates allows discrimination between multiple myeloma, monoclonal gammopathy of uncertain significance and polyclonal plasmacytosis.
    Martín P, Santón A, Bellas C.
    Histopathology; 2004 Apr 16; 44(4):375-80. PubMed ID: 15049904
    [Abstract] [Full Text] [Related]

  • 18. Biochemical markers of bone disease in asymptomatic early stage multiple myeloma. A study on their role in identifying high risk patients.
    Corso A, Arcaini L, Mangiacavalli S, Astori C, Orlandi E, Lorenzi A, Passamonti F, Klersy C, Pascutto C, Canevari-Sciorati A, Lazzarino M.
    Haematologica; 2001 Apr 16; 86(4):394-8. PubMed ID: 11325645
    [Abstract] [Full Text] [Related]

  • 19. Bone marrow angiogenesis in 400 patients with monoclonal gammopathy of undetermined significance, multiple myeloma, and primary amyloidosis.
    Rajkumar SV, Mesa RA, Fonseca R, Schroeder G, Plevak MF, Dispenzieri A, Lacy MQ, Lust JA, Witzig TE, Gertz MA, Kyle RA, Russell SJ, Greipp PR.
    Clin Cancer Res; 2002 Jul 16; 8(7):2210-6. PubMed ID: 12114422
    [Abstract] [Full Text] [Related]

  • 20. Immunophenotypic characterization of plasma cells from monoclonal gammopathy of undetermined significance patients. Implications for the differential diagnosis between MGUS and multiple myeloma.
    Ocqueteau M, Orfao A, Almeida J, Bladé J, González M, García-Sanz R, López-Berges C, Moro MJ, Hernández J, Escribano L, Caballero D, Rozman M, San Miguel JF.
    Am J Pathol; 1998 Jun 16; 152(6):1655-65. PubMed ID: 9626070
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 38.